Nicola Antonio Colabufo

Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer

Amalia Azzariti, Nicola Antonio Colabufo, Francesco Berardi et al. · Molecular Cancer Therapeutics · 2006 · 113 citations · Full text

Breast Oncology, Low Sigma, Chemoprevention Strategy +19

Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators

Rosanna Squitti, Roberta Ghidoni, Ilaria Simonelli et al. · Journal of Trace Elements in Medicine and Biology · 2017 · 97 citations · Full text

Alzheimer's Disease, Dementia, Urine Copper Indicators +5

High Affinity and Selectivity on 5-HT1A Receptor of 1-Aryl-4-[(1-tetralin)alkyl]piperazines. 2

Roberto Perrone, Francesco Berardi, Nicola Antonio Colabufo et al. · Journal of Medicinal Chemistry · 1995 · 91 citations · Full text

Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives

Nicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore et al. · Bioorganic & Medicinal Chemistry · 2007 · 80 citations · Full text

Medicinal Chemistry, Natural Sciences, Organic Chemistry +4

Structure−Affinity Relationship Study on <i>N</i>-[4-(4-Arylpiperazin-1-yl)butyl]arylcarboxamides as Potent and Selective Dopamine D₃ Receptor Ligands

Marcello Leopoldo, Francesco Berardi, Nicola Antonio Colabufo et al. · Journal of Medicinal Chemistry · 2002 · 74 citations · Full text